Results per Page:
New drug regimen prevents both chronic and acute graft-versus-host disease
From Dr. Masumi Ueda Oshima and colleagues, Clinical Research Division
Gratitude for life-saving care at Fred Hutch leads to endowed chair
Dr. Madhav Dhodapkar is the recipient of the Milton B. Rubin Family Endowed Chair
Misbehaving monocytes drive graft-versus-host disease
From the Hill Lab, Translational Science and Therapeutics Division
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger”
Aplastic anemia diagnosis took business strategy manager by surprise
Transplant replaced his failing bone marrow with healthy cells
Earlier detection for a deadly lung disease
'To have your life-threatening cancer cured, and then to die of not being able to breathe? It’s devastating.'
What’s new in combatting chronic graft-vs.-host disease
Decades after the development of bone marrow transplant, researchers are making headway against one of its most common and deadly side effects
Stem cell transplantation physician-scientist recruited from Australia to join Fred Hutch, SCCA
Dr. Geoffrey Hill will help integrate bone marrow transplantation with emerging cancer immunotherapies